Light-Guided nanoparticles could revolutionize sarcoma therapy

NCT ID NCT06599957

Recruiting now Knowledge-focused Sponsor: Istituto Ortopedico Rizzoli Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 29 times

Summary

This study is testing a new way to deliver chemotherapy directly to sarcoma tumors using tiny particles activated by light through a fiber optic cable. Researchers will work with cells and tissue samples from 30 patients aged 0 to 85 who are having surgery or a biopsy. The goal is to see if this approach works better than standard chemotherapy, with the hope of one day treating inoperable tumors or cancer that has spread.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE AND SOFT TISSUE TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori
RECRUITING

Meldola, Emilia-Romagna, 47014, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••
Istituto Ortopedico Rizzoli-OSOTT
RECRUITING

Bologna, Emilia-Romagna, 40136, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BONE AND SOFT TISSUE TUMORS